HC Wainwright Issues Pessimistic Outlook for XENE Earnings
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Xenon Pharmaceuticals in a report released on Monday, February 24th. HC Wainwright analyst D. Tsao now expects that the biopharmaceutical company will earn ($1.00) per share for the quarter, down from their prior forecast of […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Research analysts at HC Wainwright lowered their Q1 2025 EPS estimates for Xenon Pharmaceuticals in a report released on Monday, February 24th. HC Wainwright analyst D. Tsao now expects that the biopharmaceutical company will earn ($1.00) per share for the quarter, down from their prior forecast of […]
